Novadaq Technologies Inc. aggressively pursues intellectual property protection for its innovations, products and core imaging technologies in all significant markets around the world. Its strong patent strategy is focused on adding high value to its portfolio of medical devices, instrumentation and disease-specific procedures; protecting its R&D efforts; providing strategic market advantage; and delivering high return on innovation.

The company's current IP portfolio includes a total of over 100 patents and patent applications representing 34 distinct patent families. Its issued patents and pending applications continuously serve as a foundational platform for a wide array of future applications. In addition, strategic alliances and joint ventures with universities, research organizations and industry partners have resulted in mutually beneficial licensing opportunities and rights to valuable intellectual property.

To date, Novadaq has 48 granted patents and multiple pending applications in the United States, Canada, Countries of Europe, Japan, China, Hong Kong, India, South Korea, Mexico, Australia, Brazil and other markets.

The company’s entire portfolio of issued patents and published applications are available on publicly accessible patent databases.

TRADEMARKS

Novadaq Technologies Inc. takes all active steps afforded under international intellectual property laws to protect and prevent unauthorized use of its valuable trademark assets. The company's current portfolio includes both unregistered as well as registered trademarks filed with the United States Patent and Trademark Office (USPTO) and the Canadian Intellectual Property Office (CIPO).

The trademarks used in association with Novadaq’s medical devices and instrumentation, device components or consumables help establish the unique identity of the Company’s products and processes in the healthcare industry and consumer marketplace. The trademarks which are also extensively used in clinical protocols, clinical registries, promotional, advertising, instructional and reference materials further strengthen the corporate and brand identity of the Company.

With the increasing globalization of Novadaq’s R&D efforts and commercial activities, trademark registration in other international markets like Europe is currently being explored.

A representative listing of trademarks proprietary to Novadaq Technologies Inc. is given below: